Med Ad News editors rank and profile the world’s top 50 companies that generate revenue from healthcare products in this 33rd annual special report.
The Outcomes Creativity Index (OCI) represents a ranking of pharmaceutical companies and brands according to creativity and innovation. The OCI is an aggregate score-based creative achievement representing these leading U.S. and international healthcare award shows: The Outcomes LLC/Med Ad News Manny Awards; Cannes Lions; LIA: Health & Wellness; Clio Health; The One Show; The MM&M Awards; The Global Awards; and The Creative Floor Awards.
Amgen continues to set the stage for the future after a record-setting 2018, strengthening the company’s long-term ability to innovate, compete and grow.
GlaxoSmithKline’s three long-term priorities are designed to create long-term value for patients, consumers, and shareholders.
Johnson & Johnson management has outlined a strategy to deliver above-market, compound annual growth for the company’s pharmaceutical business through 2023.
Novartis is investing in the most promising frontiers of science, the most exciting innovations in the business of medicine, and the most significant healthcare needs.
Roche’s newer pharmaceutical products are generating stellar performances and have the company well-positioned for future growth.
Humira’s dominance continues as the world’s top-selling prescription product as the biologic therapy is the first drug to exceed $20 billion in annual global sales.
The Cannes Lions International Festival of Creativity’s 2019 Health Track consisting of the Pharma Lions and Health & Wellness Lions occurred in June along the scenic French Riviera.
This webinar reviews Moments That Matter through the employee lifecycle including the employee experience, attracting and retaining talent, and improving employee commitment.